应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LITS Lite Strategy Inc.
盘后交易 05-27 18:57:44 EDT
1.00
-0.05
-4.76%
盘后
1.02
+0.02
+2.00%
17:40 EDT
最高
1.06
最低
0.9851
成交量
47.12万
今开
1.03
昨收
1.05
日振幅
7.13%
总市值
3,403万
流通市值
3,051万
总股本
3,403万
成交额
47.73万
换手率
1.54%
流通股本
3,051万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Lite Strategy公布2026财年第一季度财报,成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营
投资观察 · 2025-11-20
Lite Strategy公布2026财年第一季度财报,成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营
Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作
美股速递 · 2025-11-17
Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作
加载更多
公司概况
公司名称:
Lite Strategy Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Lite Strategy, Inc.成立于2000年12月,是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。他们的候选药物管线包括voruciclib,一种口服细胞周期蛋白依赖性激酶9(CDK9)抑制剂和zandelisib,一种口服、每日一次、选择性PI3K δ抑制剂,这是一种临床前候选药物。
发行价格:
--
{"stockData":{"symbol":"LITS","market":"US","secType":"STK","nameCN":"Lite Strategy Inc.","latestPrice":1,"timestamp":1779912000000,"preClose":1.05,"halted":0,"volume":471240,"hourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":1,"latestTime":"17:40 EDT","volume":246,"amount":248.0000046,"timestamp":1779918055306,"change":0.02,"changeRate":0.02,"amplitude":0.02},"delay":0,"changeRate":-0.04761904761904766,"floatShares":30507399,"shares":34025200,"eps":-2.08,"marketStatus":"盘后交易","change":-0.05,"latestTime":"05-27 18:57:44 EDT","open":1.03,"high":1.06,"low":0.9851,"amount":477328.4208,"amplitude":0.071333,"askPrice":1.16,"askSize":200,"bidPrice":0.99,"bidSize":11300,"shortable":3,"etf":0,"ttmEps":-2.08,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1779926400000},"marketStatusCode":4,"adr":0,"listingDate":1071723600000,"exchange":"NASDAQ","adjPreClose":1.05,"preHourTrading":{"tag":"盘前","latestPrice":1.03,"preClose":1.05,"latestTime":"09:25 EDT","volume":1096,"amount":1118.8799864,"timestamp":1779888300624,"change":-0.02,"changeRate":-0.019048,"amplitude":0.009524},"postHourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":1,"latestTime":"17:40 EDT","volume":246,"amount":248.0000046,"timestamp":1779918055306,"change":0.02,"changeRate":0.02,"amplitude":0.02},"volumeRatio":0.950539,"impliedVol":0.9697,"impliedVolPercentile":0.1356},"requestUrl":"/m/hq/s/LITS","defaultTab":"news","newsList":[{"id":"1189532616","title":"Lite Strategy公布2026财年第一季度财报,成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1189532616","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189532616?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:58","pubTimestamp":1763575105,"startTime":"0","endTime":"0","summary":"Lite Strategy Inc :: *Lite Strategy公布2026财年第一季度财报,强调成功推出1亿美元Litecoin Treasury策略并进入活跃资本市场运营。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LITS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156188236","title":"Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作","url":"https://stock-news.laohu8.com/highlight/detail?id=1156188236","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156188236?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:01","pubTimestamp":1763388071,"startTime":"0","endTime":"0","summary":"Lite Strategy公布2026财年第一季度业绩;成功推出1亿美元Litecoin Treasury战略并进入活跃资本市场操作","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LITS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://litestrategy.com","stockEarnings":[{"period":"1week","weight":-0.0367},{"period":"1month","weight":-0.1102},{"period":"3month","weight":-0.1102},{"period":"6month","weight":-0.4531},{"period":"1year","weight":-0.5128},{"period":"ytd","weight":-0.2045}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.0513},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1043},{"period":"1year","weight":0.2961},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lite Strategy, Inc.成立于2000年12月,是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。他们的候选药物管线包括voruciclib,一种口服细胞周期蛋白依赖性激酶9(CDK9)抑制剂和zandelisib,一种口服、每日一次、选择性PI3K δ抑制剂,这是一种临床前候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.434783,"avgChangeRate":0.05532},{"month":2,"riseRate":0.391304,"avgChangeRate":-0.008473},{"month":3,"riseRate":0.434783,"avgChangeRate":-0.069997},{"month":4,"riseRate":0.521739,"avgChangeRate":0.018779},{"month":5,"riseRate":0.434783,"avgChangeRate":0.033767},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.082941},{"month":7,"riseRate":0.363636,"avgChangeRate":0.076909},{"month":8,"riseRate":0.380952,"avgChangeRate":-0.010903},{"month":9,"riseRate":0.52381,"avgChangeRate":0.049595},{"month":10,"riseRate":0.380952,"avgChangeRate":-0.06395},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.039907},{"month":12,"riseRate":0.227273,"avgChangeRate":0.003146}],"exchange":"NASDAQ","name":"Lite Strategy Inc.","nameEN":"Lite Strategy Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lite Strategy Inc.(LITS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lite Strategy Inc.(LITS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lite Strategy Inc.,LITS,Lite Strategy Inc.股票,Lite Strategy Inc.股票老虎,Lite Strategy Inc.股票老虎国际,Lite Strategy Inc.行情,Lite Strategy Inc.股票行情,Lite Strategy Inc.股价,Lite Strategy Inc.股市,Lite Strategy Inc.股票价格,Lite Strategy Inc.股票交易,Lite Strategy Inc.股票购买,Lite Strategy Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lite Strategy Inc.(LITS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lite Strategy Inc.(LITS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}